German regulatory authority Paul-Ehrlich-Institut has approved a phase 2/3 clinical trial in Germany of a COVID-19 vaccine candidate being developed by US pharmaceutical company Pfizer and German biotechnology company BioNTech
The German regulatory authority, the Paul-Ehrlich-Institut, has approved a phase 2/3 clinical trial in Germany of a COVID-19 vaccine candidate being developed by US pharmaceutical company Pfizer and German biotechnology company BioNTech.
“The integration of sites in Europe, and now especially in Germany, is aimed at supporting an approval in Europe," said Ugur Sahin, CEO and cofounder of BioNTech, in a news release on Monday. The BNT162b2 mRNA-based vaccine candidate is already in similar large-scale trials in the United States. The trial involves giving the participants two doses of a 30 microgram vaccine – one on the first day and one 28 days later – with participants being followed up for up to two years after they receive the second dose.
In August, the companies presented"promising" results in early data on safety and immune responses in their ongoing Phase 1/2 study in the United States. Among both younger and older adults in the trial, the companies said the vaccine"was well tolerated with mild to moderate fever in fewer than 20% of the participants.
Many infectious disease experts say, however, that it’s highly unlikely Pfizer will have enough data to allow for an emergency use authorization from the US Food and Drug Administration in October.
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
DOH: Pfizer will not conduct clinical trials for COVID-19 vaccine in PHUS-based drug manufacturer Pfizer will not hold clinical trials for its COVID-19 vaccine in the Philippines as it is “well advanced already” with its Phase 3 clinical trial, the DOH said. | DYGalvezINQ
Read more »
DOH: Pfizer will not conduct clinical trials for COVID-19 vaccine in PHUS-based drug manufacturer Pfizer will not hold clinical trials for its COVID-19 vaccine in the Philippines as it is “well advanced already” with its Phase 3 clinical trial, the DOH said. | DYGalvezINQ
Read more »
KILALANIN: Pinoy na nag-volunteer sa COVID-19 vaccine trial ng UAE
Read more »
DOH tuloy sa pakikipag-usap sa COVID-19 vaccine developers
Read more »
How will the Philippines run COVID-19 vaccine trials?
Read more »
Harris wouldn't trust Trump on pre-election virus vaccineDemocratic vice presidential nominee Kamala Harris said that if a coronavirus vaccine is available before November's election, she would not take Trump's word on its safety and efficacy.
Read more »